Abstract
At diagnosis, approximately half of myelodysplastic (MDS) patients presents a normal karyotype by conventional cytogenetic analysis (CCA). Fluorescent in situhybridization (FISH) is more sensitive than CCA allowing for the detection of minor clones and of submicroscopic lesions. We have analyzed by FISH 101 MDS patients with normal karyotype for the occurrence of the abnormalities which are most frequently observed in MDS (ie −5/5q−, −7/7q−, +8, 17p−). In 18 patients, 15 to 32% of interphase cells were found to carry one FISH abnormality. Six patients presented trisomy 8, five had del(5)(q31), five del(7)(q31), one monosomy 7 and one del(17)(p13). FISH abnormalities were more frequently observed among patients with an increased percentage of bone marrow blasts (P = 0.001). FISH abnormalities were also associated with a higher rate of progression into AML (13/18 vs 12/83, P < 0.001) and were predictive for a worse prognosis (P < 0.001). Multivariate analysis indicated that FISH positivity and IPSS risk group were independent predictors for a poor survival (P = 0.0057 and 0.0123, respectively) and for leukemic transformation (P = 0.0006 and 0.035, respectively). Leukemic transformation in FISH-positive patients was associated in all cases with an expansion of the abnormal clone. Our data demonstrated that a significant proportion of MDS patients with normal karyotype presented, if analyzed by FISH, clones of cytogenetically abnormal cells which played a determinant role in the progression of the disease. The presence of FISH abnormalities identified a group of MDS patients with normal karyotype characterized by an inferior prognosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mufti GJ . Chromosomal deletions in the myelodysplastic syndrome Leuk Res 1992 16: 35–41
Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P . Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system. A report on 408 cases Leukemia 1993 7: 1315–1323
Fenaux P, Morel P, Lai JL . Cytogenetics of myelodysplastic syndromes Semin Hematol 1996 33: 127–138
Greenberg P, Cox C, LeBeau MM, Feanux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J . International scoring system evaluating prognosis in myelodysplastic syndromes Blood 1997 89: 2079–2088
Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G . Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiologic findings Br J Haematol 1998 103: 189–197
Mauritzson N, Johansson B, Albin M, Billstrom R, Ahlgren T, Mikoczy Z, Nilsson PG, Hagmar L, Mitelman F . A single-center population based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotype features in relation to morphology, age and gender Eur J Haematol 1999 62: 95–102
Sole F, Espinet B, Sanz GF, Cevera J, Calasanz MJ, Luno E, Prieto F, Granada I, Hernandez JM, Cigudosa JC, Diez JL, Bureo E, Marques ML, Arranz E, Rios R, Climent AM, Vallespi T . Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndrome Br J Haematol 2000 108: 346–356
West RR, Stafford A, White D, Bowen DT, Padua RA . Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure Blood 2000 95: 2093–2097
De Greef GE, Hagemejer A . Molecular and cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndromes Baillière's Clin Hematol 1996 9: 1–18
Rigolin GM, Cuneo A, Roberti MG, Bardi A, Castoldi GL . Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization Haematologica 1997 82: 25–30
Rigolin GM, Howard J, Buggins A, Sneddon C, Castoldi G, Hirst WJ, Mufti GJ . Phenotypic and functional characteristics of monocyte-derived dendritic cells in patients with myelodysplastic syndromes Br J Haematol 1999 107: 844–850
Bennett JM, Catowsky D, Daniel MT, Flandrin G, Galton D, Gralnick H, Sultan C . Proposals for the classification of myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Kouides PA, Bennett JM . Morphology and classification of the myelodysplastic syndromes and their pathologic variants Semin Hematol 1996 33: 95–110
Castoldi GL, Cuneo A . Special cytological subtypes of acute myeloid leukemias and myelodysplastic syndromes Baillière's Clin Hematol 1996 9: 19–33
ISCN. Mitelman F (ed). An International System for Human Cytogenetic Nomenclature Karger: Basel 1995
Boulthwood J, Lewis S, Wainscoat JS . The 5q− syndrome Blood 1994 84: 3253–3260
Luna-Fineman S, Shannon KM, Langer BJ . Childhood monosomy 7. Epidemiology, biology and mechanistic implications Blood 1995 85: 1985–1999
Fenaux P, Jonveaux PH, Quiquandon I, Lai JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP . p53 gene mutations in acute myeloid leukemia with 17p monosomy Blood 1991 78: 1652–1657
Heaney ML, Golds DW . Myelodysplasia New Engl J Med 1999 340: 1649–1660
Cazzola M, Anderson JE, Ganser A, Hellstrom-Lindberg . A patient-oriented approach to treatment of myelodysplastic syndromes Haematologica 1998 93: 910–935
De Witte T, Van Biezen A, Hermans J, Labopin M, Runde V, Or R, Meloni G, Mauri SB, Carella A, Apperley J, Gratwohl A, Laporte JP . Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS Blood 1997 90: 3853–3857
Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Andelini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Korbling M,Keating M, Kantarjian H, Champlin R . Engraftment of allogeneichematopoietic progenitor cells with purine analog-containingchemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531–4536
Nevill TJ, Fung HC, Sheperd JD, Horsman DE, Nantel SH, Klingemann H-G, Forrest DL, Toze CL, Sutherland HJ, Hogge DE, Nalman SC, Le A, Brockington DA, Barnett MJ . Cytogenetic abnormalities in primary myelodysplastic syndromes are highly predictive of outcome after allogeneic bone marrow transplantation Blood 1998 92: 1910–1917
Cuneo A, Bigoni R, Roberti MG, Bardi A, Rigolin GM, Piva N, Mancini M, Nanni M, Alimena G, Mecucci C, Matteucci C, La Starza R, Bernasconi P, Cavigliano P, Genini E, Zaccaria A,Testoni N, Carboni C, Castoldi G . Detection and monitoring oftrisomy 8 by fluorescence in situ hybridization in acute myeloidleukemia: a multicentre study Haematologica 1998 83: 21–26
Andreasson P, Johansson B, Arheden K, Billstrom R, Mitelman F, Hogland M . Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities Genes Chromosomes Cancer 1997 2: 77–83
Westbrook CA, Hsu W-T, Litvak D, Raza A, Horrigan SK . Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia Br J Haematol 2000 110: 847–855
Jenkins RB, Le Beau MM, Kraker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa III R, Scaid DJ, Noal P, Dawald GW . Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens Blood 1992 79: 3307–3315
Fagioli F, Cuneo A, Bardi A, Carli MG, Bigoni R, Balsamo R, Previati R, Pazzi I, Roberti G, Rigolin GM, Castoldi G . Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome Cancer Genet Cytogenet 1995 82: 116–122
Flactif M, Lai JL, Preudhomme C, Fenaux P . Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes Leukemia 1994 8: 1012–1018
Fischer K, Froling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui L-P, Lichter P, Dohner H . Molecular cytogenetic deletions and translocations involving chromosome band 7q22 in myeloid leukemias Blood 1997 89: 2036–2041
Dohner K, Brown J, Hehmann U, Hetzel C, Stewart J, Lowther G, Scholl C, Froling S, Cuneo A, Tsui LC, Lichter P, Scherer SW, Dohner H . Molecular cytogenetic characterization of a critical region in bands 7q35-q36 common deleted in malignant myeloid disorders Blood 1998 92: 4031–4035
Tosi S, Harbott J, Douglas A, Hughes DM, Ross FM, Biondi A, Scherer SW, Kearney L . Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH) Leukemia 1996 10: 644–649
Jakovleva K, Ogard I, Arvidsson I, Jacobsen B, Swolin B, Hast R . Masked monosomy 7 in myelodysplastic syndromes in uncommon and of undetermined clinical significance Leuk Res 2001 25: 197–203
Horrigan SK, Arbieva ZH, Xie HY, Kravarusic J, Fulton NC, Naik H, Le TT, Westbrook CA . Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31 Blood 2000 95: 2372–2377
Bigoni R, Cuneo A, Roberti MG, Milani R, Bardi A, Cavazzini F, Minotto C, Castoldi G . Cytogenetic and molecular cytogenetic characterization of 6 new cases of hypereosinophilic syndrome Haematologica 2000 85: 486–491
Amiel A, Fridman K, Elis A, Gaber E, Manor Y, Fejgin M, Lishner M . Deletion 5q31 in patients with stable melphalan-treated multiple myeloma Cancer Genet Cytogenet 1999 13: 45–48
Gallagher A, Darley R, Padua RA . The molecular basis of myelodysplastic syndromes Haematologica 1997 82: 191–204
Acknowledgements
This work was supported by coordinated grant AIRC and MURST 60%.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rigolin, G., Bigoni, R., Milani, R. et al. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia 15, 1841–1847 (2001). https://doi.org/10.1038/sj.leu.2402293
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402293
Keywords
This article is cited by
-
Myelodysplastic syndromes: an update on molecular pathology
Clinical and Translational Oncology (2010)
-
FISH in der Diagnostik hämatologischer Neoplasien
Medizinische Genetik (2008)
-
Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome
World Journal of Pediatrics (2008)
-
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
Leukemia (2003)